Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Holding PGNY?
Track your performance easily
PGNY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.39 - $42.08
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.98M
Market Cap
$1.79B
Enterprise Value$1.36B
Total Cash (Recent Filing)$4.69M
Total Debt (Recent Filing)$1.63M
Price to Earnings (P/E)36.2
Beta1.32
Next Earnings
Mar 03, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.58
Shares Outstanding85,153,270
10 Day Avg. Volume2,137,625
30 Day Avg. Volume1,975,278
Standard Deviation0.15
R-Squared0.22
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.57
Price to Cash Flow (P/CF)10.00
P/FCF Ratio10.50
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue1.19
Enterprise Value/Gross Profit5.68
Enterprise Value/Ebitda23.40
Forecast
1Y Price Target
$19.00Price Target Upside-9.52% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Progyny News
PremiumCompany Announcements
Progyny Strengthens Leadership with New Director Appointment
Bulls Say, Bears Say
Bulls Say
Client GrowthPGNY expects to add 1.1M lives across 80 new clients, highlighting strong underlying demand for fertility benefits.
Financial PerformanceThe company pre-announced 4Q'24 earnings, expecting revenue, net income, and adjusted EBITDA to be slightly above the quarterly and full-year guidance.
Partnership ExpansionThe expansion of its partnership with CI builds on the existing relationship with Evernorth and further expands PGNY's sales reach.
Bears Say
Competitive LandscapePGNY is facing several headwinds at the same time with competition from other companies like Maven and Carrot being more aggressive.
Customer LossThe loss of its largest customer, Amazon, suggests a naturally slower growth year.
Financial PerformancePGNY shares were down 12% post a 3Q revenue/EBITDA miss and meaningful FY24 guidance cut, overshadowing a beat on the key selling season.
---
Ownership Overview
8.19% Insiders
24.97% Mutual Funds
0.28% Other Institutional Investors
34.86% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $13.39 and its highest was $42.08 in the past 12 months.
What is Progyny’s market cap?
Progyny’s market cap is $1.79B.
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Mar 03, 2025 which is in 41 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Nov 12, 2024. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.143 by -$0.033.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Overvalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is 0.1.
How many shares outstanding does Progyny have?
Progyny has 85,153,270 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.11 in its last earnings report, missing expectations of $0.143. Following the earnings report the stock price went down -19.092%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Farallon Capital Management, L.L.C.. It holds Progyny’s shares valued at 16M.
---
Progyny Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$19.00 (-9.52% Downside)
$19.00 (-9.52% Downside)
Blogger Sentiment
Bullish
PGNY Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 227.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 10.7%
Last 30 Days ▲ 10.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.01%
12-Months-Change
Fundamentals
Return on Equity
12.05%
Trailing 12-Months
Asset Growth
-9.16%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were significant achievements in terms of new client acquisitions and strategic partnerships, the quarter's financial performance was below expectations, with notable declines in ART cycles and gross margin. The client retention rate remains high, but the loss of a significant client and adjustments in guidance indicate challenges. Overall, the company is making strategic moves to strengthen its position, but variability in member activity remains a concern.Read More>---
PGNY Stock 12 Month Forecast
Average Price Target
$19.00
▼(-9.52% Downside)
Technical Analysis
Hims & Hers Health
―
Doximity
―
American Well
―
Teladoc
―
Addus Homecare
―
Encompass Health
―
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
3/20 ratings generated profit
1 Year Average Return
-19.09%
reiterated a buy rating 2 months ago
Copying Stephanie Davis's trades and holding each position for 1 Year would result in 15.00% of your transactions generating a profit, with an average return of -19.09% per trade.
---